Skip to content

Validation of the SentiCor-300 Continuous Noninvasive Blood Pressure

Clinical Validation of the SentiCor-300 Continuous Noninvasive Blood Pressure Against Invasive Arterial Blood Pressure

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05625256
Enrollment
0
Registered
2022-11-22
Start date
2023-06-30
Completion date
2024-11-30
Last updated
2023-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure

Brief summary

To compare continuous arterial pressures obtained from the SentiCor-300 with direct intra-arterial blood pressure measurements at various stages of anesthesia (such as induction, laryngoscopy, maintenance, emergence, and recovery) and after emergence in supine position.

Detailed description

Analysis of number and magnitude of BP changes Adjust endpoint calculation definitions and methods based on this lead in results Estimate sample size for main study Demonstration of capability to quantify and annotate interference in the arterial line signal and detect and changes in patient orientation Parallel recording of SentiCor-300 PPG sensor Main study: Validate SentiCor-300 noninvasive blood pressure against direct arterial pressure measurements. Up to 200 (10 run-in, the balance- study) Run in phase will be performed with Senticor-100, data will be used for sample size estimation of balance study.

Interventions

DEVICESentiCor-300

Continuous blood pressure measurement with the SentiCor-300.

Sponsors

The Cleveland Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical indication for arterial catheter insertion; * Age ≥18 years; * American Society of Anesthesiologists (ASA) physical status class ≤3; * Enrollment will be adjusted as necessary so the final population includes at least 40% men and 40% women; * Planned length of surgery \>60 minutes; * Anticipated supine positioning; * Anticipated initial recovery in the post-anesthesia care unit.

Exclusion criteria

* Severe peripheral vascular disease; * Surgery that involves manipulation of large arteries * Bypass surgery * Positive Allen's test * Inability to insert a catheter into an upper extremity artery; * Patients with an arterial-venous shunt for hemodialysis; * Inability to measure NIBP on the arm with the arterial catheter; * Atria l fibrillation; * Body Mass Index (BMI) \>35kg/m2; * Esophageal or nasopharyngeal pathology, coarctation of the aorta; * Emergency surgery. * Surgery which involves manipulation of major arteries

Design outcomes

Primary

MeasureTime frameDescription
AccuracyDuring hospital admissionThe difference between SentiCor-300 and the actual intra-arterial blood pressure for systolic and diastolic pressures.

Secondary

MeasureTime frameDescription
ChangeDuring hospital admissionComparison of continuous arterial pressures obtained from the SentiCor-300 with direct intra-arterial blood pressure measurements during hemodynamic changes at various stages of anesthesia (such as induction, laryngoscopy, maintenance, emergence, and recovery) and after emergence in various postures and positions.
Calibration DurationDuring hospital admissionTo determine how long an oscillometric calibration of the SentiCor-300 lasts.
Gender and Fitzpatrick indexDuring hospital admissionTo compare perform class analysis on accuracy versus gender and Fitzpatrick index.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026